Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 343

1.

Differential perinatal risk factors in children with attention-deficit/hyperactivity disorder by subtype.

Park S, Cho SC, Kim JW, Shin MS, Yoo HJ, Oh SM, Han DH, Cheong JH, Kim BN.

Psychiatry Res. 2014 Nov 30;219(3):609-16. doi: 10.1016/j.psychres.2014.05.036. Epub 2014 May 28.

PMID:
24997783
2.
3.

Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype.

Neuman RJ, Lobos E, Reich W, Henderson CA, Sun LW, Todd RD.

Biol Psychiatry. 2007 Jun 15;61(12):1320-8. Epub 2006 Dec 6.

PMID:
17157268
4.

Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment.

Sobanski E, Brüggemann D, Alm B, Kern S, Philipsen A, Schmalzried H, Hesslinger B, Waschkowski H, Rietschel M.

Eur Psychiatry. 2008 Mar;23(2):142-9. Epub 2007 Nov 19.

PMID:
18024089
5.

Dopamine and serotonin transporter genotypes moderate sensitivity to maternal expressed emotion: the case of conduct and emotional problems in attention deficit/hyperactivity disorder.

Sonuga-Barke EJ, Oades RD, Psychogiou L, Chen W, Franke B, Buitelaar J, Banaschewski T, Ebstein RP, Gil M, Anney R, Miranda A, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Thompson M, Asherson P, Faraone SV.

J Child Psychol Psychiatry. 2009 Sep;50(9):1052-63. doi: 10.1111/j.1469-7610.2009.02095.x. Epub 2009 Apr 14.

PMID:
19490304
6.

Interaction of dopamine transporter genotype with prenatal smoke exposure on ADHD symptoms.

Becker K, El-Faddagh M, Schmidt MH, Esser G, Laucht M.

J Pediatr. 2008 Feb;152(2):263-9. doi: 10.1016/j.jpeds.2007.07.004. Epub 2007 Oct 24.

PMID:
18206700
7.

Perinatal risk factors interacting with catechol O-methyltransferase and the serotonin transporter gene predict ASD symptoms in children with ADHD.

Nijmeijer JS, Hartman CA, Rommelse NN, Altink ME, Buschgens CJ, Fliers EA, Franke B, Minderaa RB, Ormel J, Sergeant JA, Verhulst FC, Buitelaar JK, Hoekstra PJ.

J Child Psychol Psychiatry. 2010 Nov;51(11):1242-50. doi: 10.1111/j.1469-7610.2010.02277.x. Epub 2010 Sep 24.

8.

Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample.

Laucht M, Skowronek MH, Becker K, Schmidt MH, Esser G, Schulze TG, Rietschel M.

Arch Gen Psychiatry. 2007 May;64(5):585-90.

PMID:
17485610
9.

[Risk of attention deficit/hyperactivity disorder in Aymara and Rapa-Nui school children: association with dopaminergic system polymorphisms].

Paz Lagos L, Silva C, Rothhammer P, Carrasco X, Llop E, Aboitiz F, Rothhammer F.

Rev Med Chil. 2011 May;139(5):600-5. doi: /S0034-98872011000500006. Epub 2011 Sep 16. Spanish.

10.
11.

Biological and psychosocial environmental risk factors influence symptom severity and psychiatric comorbidity in children with ADHD.

Freitag CM, Hänig S, Schneider A, Seitz C, Palmason H, Retz W, Meyer J.

J Neural Transm (Vienna). 2012 Jan;119(1):81-94. doi: 10.1007/s00702-011-0659-9. Epub 2011 May 31.

PMID:
21626412
12.

Comorbid symptom severity in attention-deficit/hyperactivity disorder: a clinical study.

Connor DF, Ford JD.

J Clin Psychiatry. 2012 May;73(5):711-7. doi: 10.4088/JCP.11m07099.

PMID:
22697195
13.

Association between the dopamine transporter gene and the inattentive subtype of attention deficit hyperactivity disorder in Taiwan.

Shang CY, Gau SS, Liu CM, Hwu HG.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):421-8. doi: 10.1016/j.pnpbp.2010.08.016. Epub 2010 Aug 26.

PMID:
20800641
14.

Clinical and genetic characteristics of Korean male alcoholics with and without attention deficit hyperactivity disorder.

Kim JW, Park CS, Hwang JW, Shin MS, Hong KE, Cho SC, Kim BN.

Alcohol Alcohol. 2006 Jul-Aug;41(4):407-11. Epub 2006 May 5.

PMID:
16679343
15.

Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity.

Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL, Cleveland HH, Sanders ML, Gard JM, Stever C.

Am J Hum Genet. 1998 Dec;63(6):1767-76.

16.

Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder.

Bellgrove MA, Johnson KA, Barry E, Mulligan A, Hawi Z, Gill M, Robertson I, Chambers CD.

Arch Gen Psychiatry. 2009 Oct;66(10):1135-42. doi: 10.1001/archgenpsychiatry.2009.120.

PMID:
19805704
17.

Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD.

Bellgrove MA, Barry E, Johnson KA, Cox M, Dáibhis A, Daly M, Hawi Z, Lambert D, Fitzgerald M, McNicholas F, Robertson IH, Gill M, Kirley A.

Neuropsychopharmacology. 2008 Sep;33(10):2536-45. Epub 2007 Nov 28.

18.
19.

Effect of candidate gene polymorphisms on the course of attention deficit hyperactivity disorder.

Biederman J, Petty CR, Ten Haagen KS, Small J, Doyle AE, Spencer T, Mick E, Monuteaux MC, Smoller JW, Faraone SV.

Psychiatry Res. 2009 Dec 30;170(2-3):199-203. doi: 10.1016/j.psychres.2008.12.016. Epub 2009 Nov 10.

Supplemental Content

Support Center